KELLI FULLER: Open Payments
NPI 1952544017 · HILLSBORO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,749 in 39 payments from 14 companies in 2025. Trend: 2023 $2,180 · 2024 $3,377 · 2025 $1,749
Food & beverage: $1,749
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $401 |
| Amgen Inc. | 3 | $255 |
| AstraZeneca Pharmaceuticals LP | 4 | $236 |
| Corcept Therapeutics | 2 | $190 |
| Boston Scientific Corporation | 2 | $164 |
| Novo Nordisk Inc | 7 | $139 |
| Tris Pharma Inc | 1 | $110 |
| PFIZER INC. | 1 | $82 |
| Lilly USA, LLC | 2 | $51 |
| Exact Sciences Corporation | 3 | $51 |
Products named: QULIPTA, Korlym, WATCHMAN FLX, VRAYLAR, FASENRA, Dyanavel XR, ZAVZPRET, Ozempic.
Industry payments across MO — which companies pay providers there.
